Lilly and Boehringer Ingelheim's (BI) Abasaglar is the first biosimilar version of the top-selling insulin analogue to hit western European markets, and could eventually take a sizeable market share.

Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive ...

OTTAWA - Elections Canada wants you to know your ballot will count whether you mark it with a pen or with a pencil. The independent agency says it’s seeing posts on social media claiming voters ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...

Shop vibrant dresses, standout activewear, and iconic Lilly Pulitzer prints for 60% off—only for 48 hours. Grab your Lilly Pop-Up Sale favorites now before sizes and styles start selling out fast.

President Trump on Thursday defended embattled French far-right leader Marine Le Pen, arguing the “witch hunt” against her is yet another instance of critics in Europe using “lawfare” to q ...

April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs.

Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock stand now. The GLP-1 agonist opportunity is gearing up for its next ...

What a difference five years can make. Just look at Eli Lilly (NYSE: LLY). In April 2020, the drugmaker stood in the shadows to some extent with companies including Johnson & Johnson, Pfizer ...

Popular right-wing politician Marine Le Pen was convicted of embezzlement by a French court and barred from running for office for five years. Speaking to her followers on Tuesday, Le Pen claimed ...

PARIS, April 27 (Reuters) - Jordan Bardella plans to be the French far-right National Rally's presidential candidate in 2027 if the party's leader Marine Le Pen remains barred from running ...